Search Form
First, enter a politician or zip code
Now, choose a category

Claire McCaskill's Public Statements on Issue: Business and Consumers

Office: U.S. Senate (MO) - Sr, Democratic
Date Title
Nov. 15, 2016 McCaskill: Boeing Move "makes perfect sense'
Oct. 27, 2016 56 Indicted in Massive IRS Impersonation Scam Arrest-- McCaskill Hails "Enormous Victory for Thousands of Victims'
Oct. 26, 2016 McCaskill: Robocall Strike Force Report the "First Clear Sign' Telecom Industry Taking Robocalls Seriously, More Work & Oversight Needed
Oct. 25, 2016 Missouri Manufacturers Can Now Claim Tariff Relief After McCaskill Reforms to Simplify Trade Law
Sept. 13, 2016 Bot and Paid For: McCaskill Takes Aim at Automated Ticket Buyers
Sept. 12, 2016 Letter to the Hon. Ernest Moniz, Secretary, U.S. Department of Energy - Goverment Accountabilty Office Report on Department of Energy Management and Operating Conctracts
Sept. 9, 2016 McCaskill, Portman Announce PSI Review of EpiPen Drug Pricing
Aug. 25, 2016 McCaskill Reacts to Mylan Announcement on Move to Increase EpiPen Rebates
Aug. 25, 2016 KSPR - Missouri's Senator Claire McCaskill Demands Answers in EpiPen Price Increase
Aug. 4, 2016 Letter to Richard Cordray, Director of the Consumer Financial Protection Bureau - Broad Coalition of Senate Democrats Call on Top Consumer Agency to Move Swiftly to Limit Unfair Arbitration Agreements in Everyday Financial Contracts
July 29, 2016 Letter to Tom Vilsack, Secretary of Agriculture - Klobuchar, Franken, Peterson Call on the U.S. Department of Agriculture to Protect U.S. Dairy Farmers from the Dairy Industry Financial Crisis
July 19, 2016 Letter to Mr. Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca Pharmaceuticals - Seeking More Information on AstraZeneca's Position That Generic Competitors to Crestor Should be Delayed
July 18, 2016 McCaskill Urges Protections for Missouri Manufacturers Against Unfair Foreign Trade Practices
July 14, 2016 Markey, Wyden, McCaskill: New Report Finds Whistleblowers at Risk at Energy Department Sites
June 27, 2016 Cable & Satellite TV Providers--McCaskill Pulls Back Curtain on Companies' Internal Workings
June 24, 2016 Missourinet - McCaskill: More Than 10,000 Missourians Overcharged by Cable Providers
June 23, 2016 Hearing of the Homeland Security and Governmental Affairs Committee - Opening Statement of Sen. Claire McCaskill, Hearing on Customer Service and Billing Practices in the Cable and Satellite Television Industry
June 23, 2016 The Washington Post - Senators Says Cable TV Users Aren't Refunded for Overcharges
June 23, 2016 St Joseph News-Press - Senate Hearing Focuses on Pay-TV Services
June 23, 2016 The Washington Post - Senate Report: Time Warner Cable is Expected to Overcharge Americans $2 Million This Year Alone
June 23, 2016 The Daily Star Journal - Pay-TV Companies Testify About Billing, Other Issues
June 23, 2016 Cable & Satellite TV Providers--McCaskill Pulls Back Curtain on Companies' Internal Workings
June 23, 2016 McClatchy DC - Senate Report: Yes, Cable Customer Service Really is That Bad
June 9, 2016 Cable, Satellite Customer Service to be Focus of McCaskill-Portman Hearing
June 8, 2016 Letter to The Honorable Tom Wheeler, Chairman, Federal Communications Commision - Protect Americans from Unwanted Robocalls and Robotexts
June 7, 2016 McCaskill Seeks Drug Pricing Information on Opioid Overdose Reversal Drugs
June 6, 2016 Chairman Collins, Ranking Member McCaskill Seek Information from Companies on Efforts to Preserve Accessibility of Opioid Overdose Reversal Drug
May 18, 2016 McCaskill Takes Wind out of Flimsy Arguments for Loosening Robocall Restrictions
May 16, 2016 Federal News Radio (DMV) - Vendor Hired to Improve Security of Opm's Network Goes Out of Business
May 13, 2016 "What on Earth Did You Think Would Happen?' -- Mccaskill, on Learning Disgraced Contractor for It Overhaul Has Now Defaulted on Contract
May 13, 2016 Letter to The Honorable Beth Cobert, Acting Director, U.S. Office of Personnel Management - Request for Information about the Office of Personal Management (OPM)
May 13, 2016 St. Louis Post-Dispatch - Congress Moves on Several St. Louis-Related Fronts
May 12, 2016 With Credit Reporting Errors Harming Missourians, McCaskill Keeps up Fight to Protect Consumers
May 12, 2016 Letter to Credit Reporting Agencies - Fighting to Protect Consumers
May 11, 2016 Federal News Radio - Senators Want New Commerce IG to Have the Authority to Do the Job Right
May 11, 2016 Missouri Manufacturers Will See Simpler Trade Processes as McCaskill Plan Heads to President's Desk
April 28, 2016 U.S. House Approves McCaskill Plan to Simplify Trade Processes for Missouri Manufacturers
April 28, 2016 McCaskill: This Business Model Uses Patients as Hostages
April 27, 2016 The New York Times - Valeant Chief, at Senate Hearing, Concedes Mistakes on Steep Drug Prices
April 27, 2016 Business Insider - Bill Ackman and Valeant Execs Just Got Through One of the Most Brutal Senate Hearings We've Ever Seen
April 27, 2016 AP - Senate Lawmakers Accused Embattled Drugmaker Valeant Pharmaceuticals of Hiking Prices to Reward Wall Street Investors at the Expense of Patients
April 27, 2016 Bloomberg - Ackman, Valeant Offer Apologies, Concessions at Drug Hearing
April 27, 2016 Hearing of the Senate Aging Committee - Sen. McCaskill's Opening Statement on "Valeant Pharmaceuticals' Business Model: the Repercussions for Patients and the Health Care System"
April 27, 2016 Washington Examiner - Senators Not Buying Drugmaker's Contrition
April 21, 2016 Postal Service "Last Mile' Pricing is Topic as McCaskill Aims to Protect Rural Delivery for Missourians
April 14, 2016 McCaskill Shines Spotlight on State of Nation's Biodefense
April 13, 2016 Valeant CEO Reverses Course: Senate Special Committee on Aging to Depose Michael Pearson
April 13, 2016 Congressional Leadership "Finally' Embraces McCaskill-Portman Reforms for American Manufacturer Tariff Relief
April 11, 2016 Senate Special Committee on Aging Calls Business Meeting to Initiate Contempt Proceedings Against Valeant CEO Michael Pearson
April 7, 2016 Letter to The Honorable Robert M. Califf, M.D., Commissioner, U.S. Food and Drug Administration - After Study Exposes Banned Rx Drugs in Dietary Supplements, McCaskill Asks FDA What They Knew and When
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top